The Center for Cancer Systems Pharmacology (CCSP) studies responsiveness and resistance to anti-cancer drugs.

How can we identify patients who will benefit from specific anti-cancer medicines and how can side-effects be minimized? Why do only some tumors respond to drugs, and why do those that do respond frequently become drug resistant? How should the choice between chemotherapy, targeted therapy and immunotherapy be made to optimize treatment for individual patients? Our team is attempting to answer these questions using precision medicine approaches that combine laboratory experiments, computation, and clinical research. The Center is committed to training students and postdocs, promoting junior faculty and ensuring that data and software are reproducible, reliable and publicly accessible.

Funding: The Center for Cancer Systems Pharmacology at Harvard Medical School is an NCI Cancer Systems Biology Center of Excellence funded by grant U54-CA225088 entitled “Systems Pharmacology of Therapeutic and Adverse Responses to Immune Checkpoint and Small Molecule Drugs

News, Events, & Updates

CSBC Announcement April, 2021:

The NCI Board of Scientific Advisors recommended reissuance of the CSBC U54 and U24 RFAs on March 16, 2021!

CSBC Steering Committee Meeting, June 9, 3-4:00 PM

Connection details circulated via email

CCSP Monthly Meeting, June 11, 3-4:30 PM

Featuring the Sorger Lab

Connection details circulated via email

Full 2021 meeting schedule

Annual CSBC Junior Investigator Meeting

August 30 – 31, 2021

To be held virtually; more details to come

Annual CSBC Consortium Meeting

September 9 – 10, 2021

To be held virtually

ABSTRACT SUBMISSION IS OPEN